Although a number of studies have revealed several roles of helenalin, e.g., mitochondrial dissipation, ROS production and NF-κB deactivation, in eliciting cytotoxicity against various tumour cells, the main anti-tumour mechanism of action has not been fully elucidated. This evidence concerns the gene NFKB1 and neoplasm.